DaVita DVA Business Sale Proceeds
Business Sale Proceeds at other companies
Other financials
Where this comes from
Reported directly by DaVita in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets.
The official record: DaVita’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about DaVita's business sale proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is DaVita's business sale proceeds?
- DaVita (DVA) reported business sale proceeds of $3.72M in Q1 2026.
- How has DaVita's business sale proceeds changed year-over-year?
- DaVita's business sale proceeds decreased by 65.1% year-over-year, from $10.67M to $3.72M.
- What is the long-term trend for DaVita's business sale proceeds?
- Over 4 years (2021 to 2025), DaVita's business sale proceeds has grown at a -13.6% compound annual growth rate (CAGR), from $61.46M to $34.17M.
- What does business sale proceeds mean?
- Cash received from selling parts of the business or entire business units.
- How do you interpret business sale proceeds?
- Higher proceeds indicate successful divestiture of non-core assets, while lower proceeds suggest a focus on organic growth or lack of divestment activity.
- How does business sale proceeds compare across companies?
- Varies significantly based on M&A cycles and portfolio restructuring strategies across healthcare peers.